Data / Form D filings / MedVector Corp
MedVector Corp: Form D filings
MedVector Corp, a biotechnology company in El Segundo, CA, filed 4 Form D notices with the SEC between 2022 and 2026. The latest, on May 6, 2026, reports $1 million sold of a $1.1 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 898 Pacific Coast Highway, El Segundo, CA, 90245
- Phone
- (310) 869-3100
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1820902
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 6, 2026 | Amendment | $1,100,000 | $1,005,000 | $95,000 | 1 | Oct 7, 2025 | sec.gov |
| Oct 16, 2025 | New notice | $1,000,000 | $1,000,000 | 1 | Oct 7, 2025 | sec.gov | |
| Nov 7, 2023 | New notice | $1,290,000 | $700,000 | $590,000 | 7 | Aug 23, 2023 | sec.gov |
| Jan 18, 2022 | New notice | $2,000,000 | $425,000 | $1,575,000 | 6 | Nov 18, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ted Barduson | Executive Officer, Director, Promoter | |
| Scott Stout | Executive Officer, Director, Promoter | |
| Ian Leaman | Executive Officer, Director, Promoter | |
| Dennis Patterson | Director | |
| Craig Lipset | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of May 4, 2026 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what MedVector Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.